{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T16:23:17Z","timestamp":1789057397753,"version":"build-2803163510"},"reference-count":20,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Actas Urol\u00f3gicas Espa\u00f1olas (English Edition)"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.acuroe.2025.501746","type":"journal-article","created":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T19:11:12Z","timestamp":1742238672000},"page":"501746","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Radiofrequency induced hyperthermia in non-muscle invasive bladder cancer: Oncologic outcomes in a real-world scenario"],"prefix":"10.1016","volume":"49","author":[{"given":"S.","family":"Mero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Oberneder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Grobet-Jeandin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Gr\u00e9goris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"S\u00e8be","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Shariat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"D\u2019Andrea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.acuroe.2025.501746_bib0005","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.eururo.2021.08.010","article-title":"European Association of Urology guidelines on non-muscle-invasive bladder cancer (Ta, T1, and carcinoma in situ)","volume":"81","author":"Babjuk","year":"2022","journal-title":"Eur Urol"},{"issue":"6","key":"10.1016\/j.acuroe.2025.501746_bib0010","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.euo.2024.06.005","article-title":"The role of Mitomycin C in intermediate-risk non-muscle-invasive bladder cancer: a systematic review and meta-analysis","volume":"7","author":"Scilipoti","year":"2024","journal-title":"Eur Urol Oncol"},{"issue":"6","key":"10.1016\/j.acuroe.2025.501746_bib0015","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.euo.2024.01.017","article-title":"Unlocking the potential of adequate bacillus Calmette-Gu\u00e9rin immunotherapy in very-high-risk non-muscle-invasive bladder carcinoma: a multicenter analysis of oncological outcomes and risk dynamics","volume":"7","author":"Subiela","year":"2024","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.acuroe.2025.501746_bib0020","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15071937","article-title":"Efficacy of different Bacillus of Calmette-Gu\u00e9rin (BCG) strains on recurrence rates among intermediate\/high-risk Non-Muscle Invasive Bladder Cancers (NMIBCs): single-arm study systematic review, cumulative and network meta-analysis","volume":"15","author":"Del Giudice","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.acuroe.2025.501746_bib0025","doi-asserted-by":"crossref","first-page":"491.e11","DOI":"10.1016\/j.urolonc.2022.06.008","article-title":"Accuracy of the CUETO, EORTC 2016 and EAU 2021 scoring models and risk stratification tables to predict outcomes in high-grade non-muscle-invasive urothelial bladder cancer","volume":"40","author":"Krajewski","year":"2022","journal-title":"Urol Oncol"},{"key":"10.1016\/j.acuroe.2025.501746_bib0030","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s00420-013-0916-3","article-title":"Screening for bladder cancer with urinary tumor markers in chemical workers with exposure to aromatic amines","volume":"87","author":"Pesch","year":"2014","journal-title":"Int Arch Occup Environ Health"},{"key":"10.1016\/j.acuroe.2025.501746_bib0035","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.eururo.2017.04.015","volume":"72","author":"Soukup","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.acuroe.2025.501746_bib0040","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/s41379-021-00955-y","article-title":"Prediction of non-muscle invasive bladder cancer recurrence using machine learning of quantitative nuclear features","volume":"35","author":"Tokuyama","year":"2022","journal-title":"Mod Pathol"},{"key":"10.1016\/j.acuroe.2025.501746_bib0045","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1097\/JU.0000000000003846","article-title":"Diagnosis and treatment of non-muscle invasive bladder cancer: AUA\/SUO guideline: 2024 amendment","volume":"211","author":"Holzbeierlein","year":"2024","journal-title":"J Urol"},{"key":"10.1016\/j.acuroe.2025.501746_bib0050","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.juro.2014.03.101","article-title":"Combined chemohyperthermia: 10-year single center experience in 160 patients with nonmuscle invasive bladder cancer","volume":"192","author":"Arends","year":"2014","journal-title":"J Urol"},{"key":"10.1016\/j.acuroe.2025.501746_bib0055","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/bjc.1988.9","article-title":"The oncogenic potential of a combination of hyperthermia and chemotherapy agents","volume":"57","author":"Komatsu","year":"1988","journal-title":"Br J Cancer"},{"key":"10.1016\/j.acuroe.2025.501746_bib0060","first-page":"1149","article-title":"Hyperthermia as a treatment for bladder cancer","volume":"24","author":"Rampersaud","year":"2010","journal-title":"Oncology (Williston Park)"},{"key":"10.1016\/j.acuroe.2025.501746_bib0065","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.addr.2020.02.004","article-title":"Hyperthermia and smart drug delivery systems for solid tumor therapy","volume":"163\u2013164","author":"Seynhaeve","year":"2020","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.acuroe.2025.501746_bib0070","series-title":"Common terminology criteria for adverse events (CTCAE) version 5.0","year":"2017"},{"key":"10.1016\/j.acuroe.2025.501746_bib0075","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13030377","article-title":"Long-term experience with radiofrequency-induced hyperthermia combined with intravesical chemotherapy for non-muscle invasive bladder cancer","volume":"13","author":"Brummelhuis","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.acuroe.2025.501746_bib0080","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.eururo.2018.09.005","volume":"75","author":"Tan","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.acuroe.2025.501746_bib0085","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S1470-2045(21)00147-9","article-title":"Pembrolizumab monotherapy for the treatment of high-risk non-muscle-invasive bladder cancer unresponsive to BCG (KEYNOTE-057): an open-label, single-arm, multicentre, phase 2 study","volume":"22","author":"Balar","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.acuroe.2025.501746_bib0090","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/JU.0000000000004020","article-title":"Efficacy of intravesical nadofaragene firadenovec for patients with Bacillus Calmette-Gu\u00e9rin-unresponsive nonmuscle-invasive bladder cancer: 5-year follow-up from a phase 3 trial","volume":"212","author":"Narayan","year":"2024","journal-title":"J Urol"},{"key":"10.1016\/j.acuroe.2025.501746_bib0095","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2200167","article-title":"IL-15 superagonist NAI in BCG-unresponsive non-muscle-invasive bladder cancer","volume":"2","author":"Chamie","year":"2023","journal-title":"NEJM Evid"},{"key":"10.1016\/j.acuroe.2025.501746_bib0100","series-title":"EAU guidelines on non-muscle-invasive bladder cancer","year":"2024"}],"container-title":["Actas Urol\u00f3gicas Espa\u00f1olas (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173578625000630?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173578625000630?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T13:09:21Z","timestamp":1748783361000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2173578625000630"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S2173578625000630"],"URL":"https:\/\/doi.org\/10.1016\/j.acuroe.2025.501746","relation":{},"ISSN":["2173-5786"],"issn-type":[{"value":"2173-5786","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radiofrequency induced hyperthermia in non-muscle invasive bladder cancer: Oncologic outcomes in a real-world scenario","name":"articletitle","label":"Article Title"},{"value":"Actas Urol\u00f3gicas Espa\u00f1olas (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acuroe.2025.501746","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.acuro.2025.501746","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Espa\u00f1a, S.L.U. on behalf of AEU.","name":"copyright","label":"Copyright"}],"article-number":"501746"}}